Amgen Inc
AMGN
ISIN null / Valor 907582
Amgen Inc
UMushroom community rating:
About company
Amgen Inc. is a global biopharmaceutical company based in Thousand Oaks, California, that discovers, develops, manufactures and markets protein- and antibody-based therapies for serious illnesses; its commercial portfolio and pipeline focus on areas such as oncology, hematology and supportive care, nephrology, bone disease, cardiovascular disease and inflammation, and it also participates in the biosimilars market. The company’s business model combines research and late-stage development of biologics with in-house manufacturing and global commercial operations, with well-known marketed products that have included Epogen and Neulasta (supporting hematologic indications), Enbrel (inflammatory disease), Repatha (cardiovascular risk) and Prolia/Xgeva (bone health). Amgen is publicly traded and derives the bulk of its revenue from therapeutic product sales while continuing to invest in R&D to replenish and expand its pipeline.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
218501 M
Market cap (USD)
2,609,055
Daily traded volume (Shares)
261.55 / 258.74
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Zoe Holloway
Kendra Ho
EQUITIES OF THE SAME SECTOR
